<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01849601</url>
  </required_header>
  <id_info>
    <org_study_id>acotec-01</org_study_id>
    <nct_id>NCT01849601</nct_id>
  </id_info>
  <brief_title>Effectiveness and Safety Study of Peripheral Balloon Dilatation Catheter in Percutaneous Transluminal Angioplasty(PTA) Procedure</brief_title>
  <official_title>A Prospective, Multicenter and Single-arm Target Value Clinical Study on the Efficacy and Safety of Peripheral Balloon Dilatation Catheter in PTA Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Acotec Scientific Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Acotec Scientific Co., Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the peripheral balloon dilatation catheter&#xD;
      (trade name: Iris) is safe an effective in PTA procedure.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>technical success rate of PTA procedure</measure>
    <time_frame>instant</time_frame>
    <description>successfully pass lesion(s)&#xD;
successfully dilate lesion(s)( diameter of balloon reach at least 90% of the nominal diameter)&#xD;
successfully retrieve&#xD;
The definition of technical success rate of PTA procedure is that, all of the above 3 point are successful</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>safety assessment</measure>
    <time_frame>day 2 to day 10 after procedure or hospital discharge</time_frame>
    <description>relevant balloon complications occurred during procedure(failure of balloon inflation, rupture of the balloon, failure of balloon deflation, failure of withdrawn, catheter fracture, etc.).&#xD;
Relevant major vascular complications occurred during procedure (rupture of blood vessels and acute vascular occlusion caused by dilation).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">167</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>PTA catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>percutaneous transluminal angioplasty balloon catheter</intervention_name>
    <arm_group_label>PTA catheter</arm_group_label>
    <other_name>PTA catheter</other_name>
    <other_name>trade name: Iris</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: 18 yrs - 80 yrs.&#xD;
&#xD;
          -  patients with iliac and / or femoral artery atherosclerotic lesions&#xD;
&#xD;
          -  Rutherford grade of 1-5;&#xD;
&#xD;
          -  Target lesion stenosisâ‰¥70% (visual estimation) (proportion of Trans-Atlantic&#xD;
             Inter-Society Consensus(TASC) B, C and D grade lesions not less than 60% )&#xD;
&#xD;
          -  Patients being able to understand the purpose of the test, and being volunteered to&#xD;
             participate in and sign the informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients not suitable for receiving interventional surgeries of lower limb arteries&#xD;
             for treatment;&#xD;
&#xD;
          -  Patients require intervention of lesions besides unilateral iliac and femoral artery&#xD;
             lesions at the same time;&#xD;
&#xD;
          -  Patients have been involved in clinical trials of other drugs or medical devices&#xD;
             within the past three months;&#xD;
&#xD;
          -  Patient is unable or unwilling to participate in this trial;&#xD;
&#xD;
          -  Patients with serious heart and brain, liver and other vital organs failure;&#xD;
&#xD;
          -  Patients with life expectancy less than 6 months;&#xD;
&#xD;
          -  Pregnant women.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Wei Guo</name>
      <address>
        <city>Beijing</city>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <study_first_submitted>April 28, 2013</study_first_submitted>
  <study_first_submitted_qc>May 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2013</study_first_posted>
  <last_update_submitted>March 19, 2015</last_update_submitted>
  <last_update_submitted_qc>March 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

